These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 8753580)

  • 1. [Porphobilinogen deaminase (PBGD)].
    Kondo M
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():891-4. PubMed ID: 8753580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Porphobilinogen deaminase (PBGD)].
    Kondo M
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():731-4. PubMed ID: 15628523
    [No Abstract]   [Full Text] [Related]  

  • 3. [Porphobilinogen deaminase (PBGD)].
    Kondo M; Daimon M
    Nihon Rinsho; 1999 Sep; 57 Suppl():352-5. PubMed ID: 10543125
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of porphobilinogen deaminase analysis in clinical tests].
    Sassa S
    Nihon Rinsho; 1989 Dec; 48 Suppl():711-4. PubMed ID: 2621989
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-viral delivery of the porphobilinogen deaminase cDNA into a mouse model of acute intermittent porphyria.
    Johansson A; Nowak G; Möller C; Harper P
    Mol Genet Metab; 2004 May; 82(1):20-6. PubMed ID: 15110317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased porphobilinogen deaminase activity in patients with malignant lymphoproliferative diseases. A helpful diagnostic test.
    Lahav M; Epstein O; Schoenfeld N; Shaklai M; Atsmon A
    JAMA; 1987 Jan; 257(1):39-42. PubMed ID: 3783901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haem precursors and porphobilinogen deaminase in erythrocytes and lymphocytes of patients with acute intermittent porphyria.
    Gross U; Jacob K; Frank M; Doss MO
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):29-35. PubMed ID: 9074786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic and molecular parameters of human hepatic porphobilinogen deaminase.
    Mazzetti MB; Tomio JM
    Biochem Int; 1990; 21(3):463-71. PubMed ID: 2222491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A porphobilinogen deaminase (PBGD) Ran-binding protein interaction is implicated in nuclear trafficking of PBGD in differentiating glioma cells.
    Greenbaum L; Katcoff DJ; Dou H; Gozlan Y; Malik Z
    Oncogene; 2003 Aug; 22(34):5221-8. PubMed ID: 12917623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haem biosynthesis in cutaneous hepatic porphyria: comparison with alcoholism and liver disease.
    Brodie MJ; Thompson GG; Moore MR; McColl KE; Goldberg A; Hardie RA; Hunter JA
    Acta Hepatogastroenterol (Stuttg); 1979 Apr; 26(2):122-8. PubMed ID: 463487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in a family with non-erythroid variant form of acute intermittent porphyria.
    Yu S; Poulos V; Stewart P
    J Hum Genet; 2000; 45(6):367-9. PubMed ID: 11185747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular genetic study of acute intermittent porphyria in Russia: mutation analysis and functional polymorphism search in porphobilinogen deaminase gene].
    Surin VL; Luchinina IuA; Selivanova DS; Pustovoĭt IaS; Karpova IS; Pivnik AV; Luk'ianenko AV; Kravchenko SK
    Genetika; 2010 Apr; 46(4):540-52. PubMed ID: 20536026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation, C to T, in exon 8 of the porphobilinogen deaminase gene in a Japanese family with acute intermittent porphyria.
    Morita Y; Daimon M; Kashiwaba M; Yamatani K; Igarashi M; Fukase N; Ohnuma H; Ikezawa Y; Sugiyama K; Manaka H
    Jpn J Hum Genet; 1995 Jun; 40(2):207-13. PubMed ID: 7663002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte porphobilinogen deaminase activity in liver diseases and proliferative diseases of the haemopoietic system and lymph nodes.
    Ostrowski J; Lutyński A; Cianciara J; Martyńska M; Kostrzewska E; Butruk E
    Mater Med Pol; 1987; 19(4):234-7. PubMed ID: 3454831
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of free and enzyme-bound intermediates in the reaction mechanism catalyzed by the bovine liver immobilized porphobilinogen deaminase. Proof that they are substrates for cosynthetase in uroporphyrinogen III biosynthesis.
    Kotler ML; Juknat AA; Fumagalli SA; Batlle AM
    Biotechnol Appl Biochem; 1991 Apr; 13(2):173-80. PubMed ID: 2043278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of 5-aminolevulinic dehydratase and porphobilinogen deaminase activities in the yolk sac membrane and liver of chick embryos.
    Pauza NL; Sopena de Kracoff YE; Ferramola de Sancovich AM; Sancovich HA
    Br Poult Sci; 2002 May; 43(2):196-203. PubMed ID: 12047082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear distribution of porphobilinogen deaminase (PBGD) in glioma cells: a regulatory role in cancer transformation?
    Greenbaum L; Gozlan Y; Schwartz D; Katcoff DJ; Malik Z
    Br J Cancer; 2002 Mar; 86(6):1006-11. PubMed ID: 11953837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphobilinogen deaminase activity in malignant proliferative disorders of the lymphatic system and bone marrow.
    Zawirska B; Usnarska-Zubkiewicz L; Gamian E
    Patol Pol; 1993; 44(1):13-7. PubMed ID: 8488077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on cow liver porphobilinogen deaminase.
    Sancovich HA; Ferramola AM; del C Batlle AM; Kivilevich A; Grinstein M
    Acta Physiol Lat Am; 1976; 26(5):379-86. PubMed ID: 1052601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.